公开(公告)号：EP3354317A1

公开(公告)日：2018-08-01

申请号：EP16849093.6

申请日：2016-09-23

申请人： Research and Development Center for Innovations

发明人： DOROHOVICH, Sergey Leonidovich ,  KAZANSKIY, Yuriy Alekseevich ,  KURACHENKO, Yuriy Aleksandrovich ,  LEBEDEV, Larion Aleksandrovich ,  LEVCHENKO, Valeriy Alekseevich ,  LEVCHENKO, Aleksandr Valerevich ,  MATUSEVICH, Evgeniy Sergeevich

IPC分类号： A61N5/10 ,  G21C1/00

CPC分类号： A61N5/1048 ,  A61N5/10 ,  A61N5/1001 ,  A61N2005/109 ,  G21C1/00 ,  G21C1/30 ,  H05H3/06 ,  Y02E30/40

摘要： The invention relates to the field of nuclear physics and medicine, and specifically to the neutron therapy of malignant tumors in humans. A coolant having a set temperature is fed into the nuclear reactor core of a medical neutron source, which is in a subcritical state. The nuclear reactor core is transitioned from the subcritical state to a critical state until the nominal power of the nuclear reactor is achieved. A neutron output channel is opened in order to conduct a neutron therapy session, and the operation of the reactor is maintained at nominal power while the neutron therapy session is conducted. At the end of the neutron therapy session, the neutron output channel is closed at the same time as the reactor core is transitioned to a subcritical state. The temperature of the coolant entering the core is maintained un-changed and equal to a set temperature, both when the core is transitioned to a critical state and during the operation of the nuclear reactor at nominal power.